UK becomes first country to approve Omicron vaccine from Moderna
BeGenomics
An updated version of the COVID-19 vaccine made by Moderna that targets two coronavirus variants approved by the MHPRA, UK.
BeGenomics
The original vaccines used in the pandemic were designed to train the body to fight the first form of the virus that emerged in Wuhan, in China, at the end of 2019.
BeGenomics
The company said its updated booster also showed a "potent" response against the BA.4 and BA.5 subvariants.
BeGenomics
All over-50s and people in high-risk groups will be offered some form of booster from next month.
BeGenomics
“No serious safety concerns were identified," the UK government
BeGenomics
The results of experiments on 437 people showed the updated vaccine was safe and gave better immune protection against newer variants.
BeGenomics
In June, Pfizer and BioNTech tested two Covid-19 vaccine boosters to target the Omicron variant.
BeGenomics
Britain's Joint Committee on Vaccination and Immunisation (JCVI) is now expected to issue a recommendation soon on how the vaccine should be deployed in the country.
According to Moderna, trial showed its variant-adapted booster generated virus-neutralizing antibody levels against the subvariants that were 1.69 times higher than those given the original.